Dr. Stephen G. Odaibo is Chief Executive Officer and Founder of Quantum Lucid Research Laboratories. He is a Mathematician, Computer scientist, Physicist, Biochemist, and Physician. Dr. Odaibo obtained a B.S. in Mathematics (UAB, 2001), M.S. in Mathematics (UAB, 2002), M.S. in Computer Science (Duke, 2009), and Doctor of Medicine (Duke, 2010). From 2004-2006, he studied beta-arrestin mediated GPCR signaling in the Laboratory of Robert J. Lefkowitz, 2012 Nobel Laureate in Chemistry. Dr. Odaibo completed a housemanship in Internal Medicine at Duke University Hospital and is currently an Ophthalmology resident at Howard University Hospital in Washington DC. His awards and recognitions include:… he invented the Trajectron method and provided the first quantitative demonstration of non-paraxial light bending within the human cornea; his first paper was selected by MIT Technology Review as one of the best papers from Physics or Computer science submitted to the arXiv the first week of Oct 2011; he was an Invited Discussant to the exclusive launching of the U.S. National Academy of Sciences Committee Report,�Optics and Photonics: Essential Technologies for Our Nation; he won the Barrie Hurwitz Award for Excellence in Clinical Neurology (Duke, 2005); he won the International Scholar Award for Academic Excellence (UAB, 2001); and in 2012 he was selected as a Featured Alumnus of the Mathematics Department at UAB. Dr. Odaibo's research interests are at the fusion of Mathematics, Computer Science, Physics, and the Biomedical Sciences, with a special focus on the interaction of light with biological systems. His interests also include exploring approaches towards pedagogical unification of the Natural Sciences and Biotechnology disciplines. He is happily married to Dr. Lisa Odaibo who is completing a residency in Pediatrics.